Accepted: 8 April 2020
First Online: 26 May 2020
Change Date: 1 June 2020
Change Type: Update
Change Details: Fig. 2 file initially published online was corrupted and was replaced on 1/6/20.
: M.A.K. received salary, consulting fees, honoraria or research funds from Roche, Bristol–Meyers Squibb, AbbVie and Cell Applications, and is an employee of Roche. M.A.K. holds a patent on the use of antibiotics and commensal vaccination to treat autoimmunity and received royalties. T.M.G. received research funds from Eli Lilly and Company and Janssen Scientific Affairs. W.E.R. declares no competing interests.